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With the availability of many sophisticated technologies for
manipulating its genome, the mouse is the favored experimen-
tal mammal for studying many basic biological processes and
for developing models relevant to human disease. Its pre-
eminent position has only been strengthened by the recent
publication in Nature of papers detailing the analysis of the
draft mouse genome sequence [1] and the annotation of a
major set of full-length mouse cDNAs [2]. Using experience
and data gained from the human genome annotation, as well as
mouse cDNA data and the important RIKEN cDNA resource
[2], an estimate of 29,000 protein-coding genes has been
made. The continued refinement of gene-prediction algo-
rithms, combined with ongoing efforts to develop increasing
numbers of sequenced full-length cDNA libraries, should lead
to better and better understanding of the nature and number of
protein-coding genes in the mouse genome. Indeed, a recent
paper using a two-stage de novo gene prediction procedure has
added over 1,000 new genes to the mouse gene list [3]. There
are still major gaps to be filled in the gene-prediction area,
most notably in the definition of single-exon genes and in all
the different forms of RNA-encoding genes, but the availability
of the list of protein-encoding genes provides an exciting com-
pendium of the component parts of a mouse. 
Availability of the sequence of so many genes immediately
spawns a wish-list of all the additional information needed
to truly understand their function. Here are just some of the
issues that now need to be addressed in the same kind of
genome-wide detail as the sequence acquisition. How many
splicing variants are there and how functionally important
are they? How are all the transcripts expressed in time and
space, from egg to adult? And where are all the proteins
expressed - including intracellular location - from egg to
adult? What are the post-translational protein modifications,
their distribution and functional importance? What are the
dynamics of protein-protein interactions in time and space?
What are the effects of genetic gain or loss of function - for all
kinds of alleles, from null or conditional to point mutations.
What are the gene-gene and gene-environment interactions,
and what are their effects? How is the temporal and spatial
regulation of transcription and translation achieved? How do
the protein-coding sequences and gene regulation differ
across species? And can we identify the genes important for
susceptibility and resistance to disease? The set of genome
papers does not provide answers to all these questions, but it
does point to the road ahead in various ways.
How many splicing variants are there?
Although the analysis of both the human and the mouse
genome sequences has produced a smaller than expected
estimate of the number of protein-coding genes, it is clear
Abstract
The recent flurry of papers on the mouse genome includes the description of the full genome assembly,
analysis of the mouse transcriptome, the origin of interstrain variation, initial analysis of conserved
non-coding regions and high-throughput expression analysis of a subset of genes. Each illustrates how
the availability of the genome sequence will change the way mouse biologists do business in future.that complexity can be increased by alternative splicing,
generating different protein-coding forms. Genome
sequence analysis and exon prediction per se cannot distin-
guish which exons are included in the final transcripts, but
comparison with cDNAs and expressed sequence tags (ESTs)
can give an estimate of the extent of alternate splicing. When
60,000 RIKEN clone sequences and 44,000 mRNAs in the
public databases were aligned with the genome assembly [2],
41% of the resulting transcript clusters showed evidence for
alternative spliced forms; and 79% of putative splice variants
would produce altered protein sequence. These numbers
provide a lower limit on the extent and effect of alternative
splicing in the mouse: not all transcripts are represented in
the current cDNA libraries and not all functional splice vari-
ants lead to protein-coding changes. But these numbers
already indicate that alternative splicing is an important
contributor to the functional complexity of the mammalian
transcriptome. In humans it is often difficult to fully validate
whether a predicted exon represents an alternate splice form,
because rare transcripts may occur in tissues that are not
readily accessible, such as the embryo. The mouse provides
a much more accessible model for pursuing the extent of
alternative splicing. We will need more cDNA libraries
from unusual tissue and cell types, and the development
of oligonucleotide-based exon arrays to validate expression of
spliced forms. Determining the functional consequences
of alternative transcripts, whether coding or non-coding, will
require genetic disruption of the different forms, a procedure
readily achievable in the mouse by gene targeting.
Gene-expression profiling
Once all the transcriptional units, whether coding or non-
coding, and all their spliced forms, are fully annotated, some
aspects of function may be predicted on the basis of
sequence analysis alone. But much more information is
needed if we are to understand how individual genes act
together to produce the complex biology of the organism.
Detailed patterns of transcript expression at all stages of
development from egg to adult provide the basis for further
investigations in individual tissues and organs. Two papers
in the ‘mouse genome issue’ of Nature  provide an initial
analysis of the expression of all identifiable mouse orthologs
of the genes on human chromosome 21 [4,5]. Both groups
used in situ hybridization to different embryonic stages and,
in the case of Gitton et al. [5], sections of the neonatal brain,
to start building an expression database. Although some
interesting expression patterns were observed for novel
genes, the papers largely serve to illustrate the limitations of
current approaches and the scale of the task ahead. Levels of
expression are difficult to quantitate by in situ hybridization,
making cross-comparison between datasets difficult. Use of
more quantitative measures, such as RT-PCR and micro-
array analysis, can help, but such studies lose the important
spatial expression details available from in situ approaches.
Use of reporter genes, such as green fluorescent protein
(GFP) or -galactosidase (lacZ), simplifies the detection of
expression and can potentially be quantifiable. Efforts to gen-
erate large numbers of reporter transgenic strains of mouse
[6] or targeted knock-in strains are under way. Embryonic
stem-cell lines carrying insertions of reporter genes such as
GFP and lacZ within every gene in the genome are currently
being generated in large-scale gene-trap screens [7] and will
provide the most extensive resource of reporter lines for in
situ gene-expression analysis in the mouse.
The number of stages, tissues and conditions under which
one would like to assess gene expression is mind-boggling:
how can one deal with the huge amounts of data that would
be generated? Static, non-searchable presentation of expres-
sion data in the form of images of whole embryos or tissue
sections is woefully inadequate for in-depth mining of the
functional significance of expression patterns. Ideally, gene
expression data would be presented in a three-dimensional,
searchable format, a task currently being undertaken by the
Emage group at the University of Edinburgh [8] (Table 1
lists useful websites relevant to this article). It is critical that
expression data of the sort presented in the recent papers
[4,5] is placed in the searchable fields of the text-based Gene
Expression Database (GXD) [9] and the image-based Emage
database [8]. Methodologies to acquire gene-expression pat-
terns in three dimensions, such as optical projection tomog-
raphy [10], will be important tools in aiding the construction
of large-scale expression databases. 
Determination of transcript localization is, of course, only
the first step in a comprehensive expression analysis.
Protein localization and protein-protein interactions need to
be analyzed at the tissue level, and, importantly, at the sub-
cellular level. This will require a major effort aimed at gener-
ating a collection of isoform-specific antibodies for the
products of all the genes in the genome. Among its other
uses, the RIKEN full-length cDNA resource is an ideal sub-
strate for such an undertaking, emphasizing again the
importance of the rapid and unfettered distribution of this
resource to the world-wide community.
Genome-wide functional analysis
The availability of the draft mouse genome sequence, com-
bined with the excellent resources of genomic DNA cloned
within manageable bacterial artificial chromosomes (BACs)
[11], have already made much simpler the process of generat-
ing targeting vectors for gene mutation in embryonic stem
(ES) cells. Further enhancement could be provided by an
effort to produce sequence-annotated arrayed libraries of the
genome in ready-to-use targeting vectors. Indeed, it is now
not entirely unrealistic to consider the goal of generating a
targeted mutation in every gene in the genome, at least within
ES cells. The problem is that one mutation in a gene is not
likely to be enough for full functional analysis. It may be
better, therefore, to use less expensive means of generating
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the more precise tools of gene targeting for those genes
whose functions are revealed as critical for specific biological
processes. Gene-trap mutagenesis is a random mutagenesis
approach that generates large numbers of sequence-tagged
insertions in the genome of ES cells, each of which interrupts
the coding sequence of a gene [7]. Large-scale efforts to gen-
erate libraries of gene-trap insertions are under way world-
wide, and it is now very easy to assign the sequence tag from
each gene-trap insertion to its position in the genome,
making gene trapping a powerful means of rapidly assessing
gene function. Potentially even more rapid would be the use
of short-interfering RNA (siRNA) to knock-down gene
expression in vivo [12,13]. Again the availability of genomic
and cDNA sequence makes it easy to design blocking siRNAs
for any gene of interest.
Even if every gene is known and every gene can be mutated in
a sequence-driven manner, this will not provide a complete
analysis of the function of the mouse genome. Phenotype-
driven approaches will continue to provide insight into the
extent to which genetic alterations can contribute to complex
traits. Mutagenesis programs using the chemical ethyl-
nitrosourea (ENU) are producing large numbers of pheno-
types relevant to human diseases that have to be mapped to a
chromosomal region and then positionally cloned. The public
sequencing consortium undertook full sequencing of only one
inbred mouse strain, C57BL/6J, but it also performed partial
sequencing of several other strains and was able to generate a
resource of single-nucleotide polymorphisms (SNPs) across
the genome [14]. These can be used for mapping purposes
and then the draft sequence can be used to identify candidate
genes for further analysis. The number of spontaneous and
ENU-induced mutations positionally cloned by this hybrid
mapping/candidate-gene approach is increasing rapidly and
is certainly enhanced by the availability of the genome
sequence and the SNP resource.
Available mouse inbred strains also show intrinsic pheno-
typic variations that can be mapped as quantitative trait loci
(QTLs) or genetic modifiers of other mutations. The Mouse
Phenome Project [15] is an initiative that is undertaking a
detailed baseline analysis of as many different phenotypes as
possible in a set of inbred strains, and this will help to char-
acterize strain-specific variation. Identifying the genetic
basis of the variation underlying such traits is notoriously
difficult, however. How will sequence information help?
High-quality sequence information from multiple strains
would of course help to identify functional variation in can-
didate genes mapping to a QTL. But this is not likely to be a
feature of the public sequencing effort and is only minimally
available in the private domain. The SNP resource does,
however, provide some idea of the extent of DNA sequence
variation between inbred strains. What is particularly inter-
esting about the available SNP analysis is that there are
SNP-rich and SNP-poor regions of the genome when com-
paring any two inbred strains. Further analysis of SNP dis-
tribution among strains led Wade et al. [16] to conclude that
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Table 1
Useful websites 
Mouse genome sequence browsers
Ensembl mouse genome server http://www.ensembl.org/Mus_musculus/
NCBI mouse genome resource http://www.ncbi.nih.gov/genome/guide/mouse/
UCSC mouse genome browser gateway http://genome.ucsc.edu/cgi-bin/hgGateway?org=mouse
Gene expression databases
Mouse Genome Informatics - gene expression http://www.informatics.jax.org/menus/expression_menu.shtml
Edinburgh Mouse Atlas Project (emap) http://genex.hgu.mrc.ac.uk
Gene-trap databases
German GeneTrap Consortium http://www.genetrap.de
Mammalian Functional Genomics Centre http://www.escells.ca
Bay Genomics gene trap resource http://baygenomics.ucsf.edu/
Centre for Modeling Human Diseases (CHMD) - gene trap core http://www.cmhd.ca/sub/genetrap.asp
SNP resources
SNPview http://www.GNF.org/SNP
Whitehead Institute mouse SNP data http://www-genome.wi.mit.edu/snp/mouse
Roche mouse SNP database http://mouseSNP.roche.com
The RIKEN FANTOM2 cDNA resource http://fantom2.gsc.riken.go.jp/most existing mouse strains essentially represent recombi-
nant inbred strains between the two founder species leading
to the laboratory mouse, namely Mus musculus and  Mus
domesticus. In practice, this means that researchers under-
taking a mapping backcross need to be aware of whether the
region of interest is SNP-rich or SNP-poor between the two
strains of interest. 
It has been argued that the haplotype block structure of
inbred strains, as revealed by SNP analysis, can be helpful in
identifying the basis of QTLs, since the search for candidate
differences between two strains can be restricted to regions
where they are highly divergent [17]. But this assumes that
important QTLs reside in the original species-wide variation
introduced into the gene pool of the inbred strains. QTLs
might instead represent recent variants specific to a given
strain and might reside in SNP-poor domains. The two sce-
narios can be distinguished if the haplotype structure of the
major inbred strains is known and can be associated with
specific phenotypes. There is thus clearly a need for a
‘HapMap’ of the mouse genome, as has recently been pro-
posed as a means of associating phenotype with map posi-
tion in humans [18]. A recent paper by Wiltshire et al. [19] is
a first step in this direction. It describes haplotype patterns
of SNPs across eight inbred strains of mice.
Gene regulation
One of the key issues in dealing with the complexity of gene
function in the living organism is to understand how gene
expression is regulated in a cell-, tissue- and developmen-
tal-stage-specific manner. We know that control of gene
transcription depends ultimately of the activity of transcrip-
tion factors that bind to regulatory elements close to the
gene of interest. We also know that such sites are likely to
be conserved across evolution. The sequence analysis of the
mouse genome did not make a strong effort to use the
genome sequence to identify such elements, but the authors
did estimate that fully 5% of the genome of the mouse is
under selection [1] when compared with human sequence:
this is a much higher proportion than is predicted on the
basis of conserved coding sequences alone. Some of this
sequence under selection may represent RNA genes, chro-
matin structural elements, and so on [20], but much of it is
likely to represent regulatory elements. Although compari-
son of mouse and human sequences located near genes can
help to identify conserved regulatory elements, it is not easy
to find such elements based on comparisons of only two
sequences. Comparative genomic analysis - sequencing
whole genomes or selected regions from multiple genomes
and then looking for conserved elements - can be very
useful in identifying conserved regulatory elements; and a
number of algorithms have been developed to support such
analysis. There is a bit of a paradox, however: analysis to
date has focused on identifying conserved elements in genes
regulated identically across evolution; but many of the
genetic changes that drive evolution are likely to be due to
changes in gene regulation, and comparative sequence
analysis needs to be able to identify these elements as well.
Eventually there will be sufficient sequence available for
many different species that some of these evolutionary
questions will be resolved.
The mouse genome assembly has now been published in the
formal literature, as has the draft Fugu genome sequence
[21], and an assembly of the rat genome sequence is available
online [22]. We can expect the whole-genome draft
sequences of other vertebrates to follow in quick succession,
making this the coming era of comparative vertebrate
genomics. But the mouse still leads the way as an all-round
system for in-depth analysis of genome function from proteins
to disease, and is likely to continue to do so for many years
to come.
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